Chronotherapeutic Film-Coated Pulsatile Drug Delivery System of Resveratrol for the Management of Rheumatoid Arthritis
Journal of Pharma Insights and Research · 05.06.2026 · 4 (3) · 420-429
DOI: 10.69613/p6mfq735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharma Insights and Research, online erschienen am 05.06.2026. Verfasst von Neelam Nain und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Circadian fluctuations in inflammatory cytokine production exacerbate joint pain, stiffness, and clinical pathology during early morning hours in rheumatoid arthritis patients. Standard immediate-release drug formulations fail to provide targeted drug availability during these peak symptomatic windows. Synchronizing therapeutic drug delivery with biological rhythms offers a targeted approach to mitigate nocturnal inflammatory cascades. A chronotherapeutic pulsatile dosage form was developed using a polymer-coated tablet core containing resveratrol to achieve time-controlled release after a predetermined delay period. Preformulation characterization confirmed the lipophilic nature (log P = 3.12 ± 0.05), melting point range (254 ± 0.62 °C), and spectroscopic absorption maximum (λmax = 303 nm) of resveratrol. Fourier-transform infrared spectroscopy revealed no chemical interaction between the drug and formulation excipients. Core tablets prepared via direct compression were evaluated for mechanical integrity, mass variation, friability, and disintegration time. The optimized core tablet (F4) exhibited superior mechanical strength (4.1 ± 0.3 kg/cm2), acceptable friability (0.91%), and rapid core disintegration. Application of a hydrophobic film coating comprising ethyl cellulose (95%) and dibutyl phthalate (5%) established a functional polymeric barrier that delayed initial fluid ingress. Coated tablets displayed enhanced hardness (5.2 ± 0.3 kg/cm2), low friability (0.57%), and an extended disintegration lag phase (31.2 ± 0.9 min). In-vitro dissolution showed a defined lag period followed by rapid drug release, attaining 88.4% cumulative release within 60 minutes. The system successfully delays drug release while providing targeted anti-inflammatory action aligned with early morning arthritic exacerbations
Zitieren
APA
Nain, N., Rajput, S. S., Madhariya, R., Paul, S. D., & Shrivastava, S. (2026). Chronotherapeutic Film-Coated Pulsatile Drug Delivery System of Resveratrol for the Management of Rheumatoid Arthritis. Journal of Pharma Insights and Research, 4(3), 420-429. https://doi.org/10.69613/p6mfq735
Vancouver
Nain N, Rajput SS, Madhariya R, Paul SD, Shrivastava S. Chronotherapeutic Film-Coated Pulsatile Drug Delivery System of Resveratrol for the Management of Rheumatoid Arthritis. Journal of Pharma Insights and Research. 2026;4(3):420-429. doi:10.69613/p6mfq735
BibTeX
@article{Nain2026,
author = {Nain, Neelam and Rajput, Saket Singh and Madhariya, Rashmi and Paul, Swarnali Das and Shrivastava, Suman},
title = {Chronotherapeutic Film-Coated Pulsatile Drug Delivery System of Resveratrol for the Management of Rheumatoid Arthritis},
journal = {Journal of Pharma Insights and Research},
year = {2026},
volume = {4},
number = {3},
pages = {420--429},
doi = {10.69613/p6mfq735}
}
EUVIMED